retatrutide causing diarrhea experimental weight-loss drug side effects and concerns Annals - Retatrutide, a triple-hormone

Ozempic Lawsuit for Deep Vein Thrombosis (DVT), Blood Clot, or Pulmonary Embolism The Endocrine Journal reported that people taking Ozempic or other semaglutide medications were more than three times as likely to develop deep vein thrombosis (DVT)

For years, she told her patients to eat less and exercise more

Recent findings published in the Annals of Internal Medicine reveal that retatrutide has the potential to outperform current treatments like Ozempic and Wegovy in promoting weight loss. In trials reviewed by researchers from McGill University, retatrutide demonstrated weight reductions of up to 22.1% of participants' starting weight within 48 weeks

To understand why screening matters, it helps to know how these drugs work

In 2007, Kowalchick et al